134 related articles for article (PubMed ID: 34923150)
1. Occult alloimmunization to the D antigen (RhD) related to graft versus host disease and its treatment.
Badami KG; O'Brien J; Prestidge T
Transfus Clin Biol; 2022 May; 29(2):175-176. PubMed ID: 34923150
[TBL] [Abstract][Full Text] [Related]
2. Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.
Yazer MH; Spinella PC; Sperry J; Triulzi DJ; Leeper C
Transfusion; 2023 May; 63 Suppl 3():S54-S59. PubMed ID: 37067374
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of D- red blood cell transfusion and rituximab therapy in autoimmune hemolytic anemia with anti-D and panreactive autoantibodies arising after hematopoietic stem cell transplant.
Minakawa K; Ohto H; Yasuda H; Saito S; Kawabata K; Ogawa K; Nollet KE; Ikeda K
Transfusion; 2018 Jul; 58(7):1606-1610. PubMed ID: 29664112
[TBL] [Abstract][Full Text] [Related]
4. Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Gjærde LK; Sørensen ALT; von Stemann JH; Fischer-Nielsen A; Hansen MB; Sengeløv H; Ostrowski SR
Transplant Cell Ther; 2021 Oct; 27(10):866.e1-866.e9. PubMed ID: 34252580
[TBL] [Abstract][Full Text] [Related]
5. Cancer type predicts alloimmunization following RhD-incompatible RBC transfusions.
Arora K; Kelley J; Sui D; Ning J; Martinez F; Lichtiger B; Tholpady A
Transfusion; 2017 Apr; 57(4):952-958. PubMed ID: 28191636
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic peripheral blood hematopoietic stem cell transplantation: guidelines for red blood cell immuno-hematological assessment and transfusion practice.Société Française de Greffe de Moelle.
Lapierre V; Kuentz M; Tiberghien P
Bone Marrow Transplant; 2000 Mar; 25(5):507-12. PubMed ID: 10713627
[TBL] [Abstract][Full Text] [Related]
7. Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
Seheult JN; Callum J; Delaney M; Drake R; Dunbar NM; Harm SK; Hess JR; Jackson BP; Javanbakht A; Moore SA; Murphy MF; Raval JS; Staves J; Tuott EE; Wendel S; Ziman A; Yazer MH;
Transfusion; 2022 Aug; 62 Suppl 1():S185-S192. PubMed ID: 35748692
[TBL] [Abstract][Full Text] [Related]
8. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
Yazer MH; Triulzi DJ; Sperry JL; Seheult JN
Transfusion; 2021 Jul; 61 Suppl 1():S150-S158. PubMed ID: 34269438
[TBL] [Abstract][Full Text] [Related]
9. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
10. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.
Dahl D; Hahn A; Koenecke C; Heuft HG; Dammann E; Stadler M; Buchholz S; Krauter J; Eder M; Sykora KW; Klein C; Ganser A; Sauer M
Transfusion; 2010 Mar; 50(3):649-55. PubMed ID: 19929861
[TBL] [Abstract][Full Text] [Related]
11. Human leucocyte antigen alloimmunization after bone marrow transplantation: an association with chronic myelogenous leukaemia.
Geiger TL; Woodard P; Tong X; Srivastava DK; Johnson R; Turner V; Hale G; Richardson S
Br J Haematol; 2002 Jun; 117(3):634-41. PubMed ID: 12028035
[TBL] [Abstract][Full Text] [Related]
12. Alloimmunization to RhD antigen in RhD-incompatible haemopoietic cell transplants with non-myeloablative conditioning.
Mijovic A
Vox Sang; 2002 Nov; 83(4):358-62. PubMed ID: 12437524
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies.
Irschick EU; Hladik F; Niederwieser D; Nussbaumer W; Holler E; Kaminski E; Huber C
Blood; 1992 Mar; 79(6):1622-8. PubMed ID: 1547351
[TBL] [Abstract][Full Text] [Related]
14. High Levels of CXCL8 and Low Levels of CXCL9 and CXCL10 in Women with Maternal RhD Alloimmunization.
Schettini JAC; Gomes TV; Santos Barreto AK; da Silva Júnior CD; da Matta M; Coutinho ICN; de Oliveira MDCVC; Torres LC
Front Immunol; 2017; 8():700. PubMed ID: 28717357
[TBL] [Abstract][Full Text] [Related]
15. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation.
Franchini M; Gandini G; Aprili G
Bone Marrow Transplant; 2004 Jun; 33(12):1169-72. PubMed ID: 15094753
[TBL] [Abstract][Full Text] [Related]
16. Anti-D Alloimmunization After RhD Positive Red Cell Transfusion to Selected RhD Negative Patients.
Pandey P; Setya D; Singh MK
Indian J Hematol Blood Transfus; 2022 Jul; 38(3):577-584. PubMed ID: 35747571
[TBL] [Abstract][Full Text] [Related]
17. The impact of pre-existing HLA and red blood cell antibodies on transfusion support and engraftment in sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation from HLA-matched sibling donors: A prospective, single-center, observational study.
Nickel RS; Flegel WA; Adams SD; Hendrickson JE; Liang H; Tisdale JF; Hsieh MM
EClinicalMedicine; 2020 Jul; 24():100432. PubMed ID: 32637902
[TBL] [Abstract][Full Text] [Related]
18. Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review.
Yazer M; Triulzi D; Sperry J; Corcos A; Seheult J
Hematology; 2021 Dec; 26(1):321-327. PubMed ID: 33775237
[TBL] [Abstract][Full Text] [Related]
19. [Allogeneic peripheral blood stem cell transplantation (allo PBSCT) compared with allogeneic bone marrow transplantation (allo BMT)].
Tanaka J
Rinsho Ketsueki; 2002 Jun; 43(6):442-6. PubMed ID: 12134697
[No Abstract] [Full Text] [Related]
20. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients.
Asfour M; Narvios A; Lichtiger B
MedGenMed; 2004 Jul; 6(3):22. PubMed ID: 15520646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
